Pfizer provides update on oral GLP-1 receptor agonist danuglipron
In todays GLP-1 boom, more and more prescriptions are beginning not inside a doctors office, but inside an algorithm
GLP-1s can help women before undergoing IVF Early research suggests that short-term GLP-1 use before IVF, often combined with metformin, may help some patients lose enough weight to meet clinic or anesthesia BMI limits and improve overall metabolic health before treatment
Researchers are exploring nanoparticle carriers, enzyme inhibitors, and absorption enhancers to make daily oral GLP-1s easier to take and potentially more effective
The current recommendation is to stop semaglutide at least 2 months before planned pregnancy and tirzepatide at least 1 month before
Next-generation oral GLP-1 medications Orforglipron is a non-peptide oral GLP-1 receptor agonist in late-stage clinical trials